William R. Dinwoodie, MD

BOARD CERTIFICATION:
          •  Medical Oncology

FELLOWSHIP:
          •  University of South Florida College of Medicine - Medical Oncology

RESIDENCY:
          •  University of South Florida College of Medicine - Internal Medicine

MEDICAL SCHOOL:
          •  Indiana University - MD

• Fishman M, Garrett C, Simon G, Chiappori A, Lush R, Dinwoodie W, Mahany J, Dellaportas A, Cantor A, Gollerki A, Cohen M, Sullivan D. Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies. Clin Cancer Res. 2006 Jan;12(2):523-528. Pubmedid: 16428495.


• Kim C, Yeatman T, Coppola D, Trotti A, Williams B, Barthel J, Dinwoodie W, Karl R, Marcet J. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg. 2001;234(3):352-358. Pubmedid: 11524588.


• Spiers A, Saba H, Vieson K, Ballester O, Moscinski L, Dinwoodie W. Mycosis fungoides and Sezary syndrome: treatment with carboplatin and etoposide by continuous intravenous infusion. Blood. 1994;84:169a-169a.

Dr. William Dinwoodie is a medical oncologist in the Department of Gastrointestinal Oncology at Moffitt Cancer Center and medical director of the Moffitt GI Clinic.  He is an associate professor at the University of South Florida College of Medicine Department of Oncologic Sciences.
Dr. Dinwoodie’s research focuses on novel therapies for gastro-intestinal malignancies, especially colon, pancreatic, and gastric and esophageal cancers.  His clinical interests include colorectal cancer, gastro-esophageal cancer and biliary tract cancer.
A graduate of Indiana University School of Medicine, Dr. Dinwoodie completed a residency in internal medicine and a fellowship in hematology/oncology at USF.
Dr. Dinwoodie is a former acting chief of oncology at James A. Haley Medical Center, Veterans Administration Hospital in Tampa, and former director of Moffitt’s Pain Service.  He is a member of numerous professional organizations, including the American Society of Clinical Oncology, American Pain Society, International Association for the Study of Pain, and Eastern Cooperative Oncology Group.  He is widely published and serves as an editorial reviewer for Moffitt’s Cancer Control Journal.